Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age23-45
SponsorNew York State Psychiatric Institute

About this trial

This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among those already receiving AB in which 300 families will be randomized in a 1:1 ratio to receive either a high ($40/month) or low ($2/month) supplemental transfer for 2 years. Three hundred children (index child participants; 7-10 years old) will be enrolled across both study arms. Additionally, up to 150 siblings ("sibling participants;" 7-10 years old) will be enrolled. Eligible families who decide to participate will sign a study-specific informed consent (mother) and assent (child) form. The UNIFESP team will conduct the respective assessments at baseline, approximately 8- and 16- months, 24-months and approximately 6-months post-RCT.

Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment.

Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol.

Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.

Eligibility criteria

Qualifiers

Age 23-45 years old

Receiving AB cash transfers

Has at least two or more children ages 7- 10 years old at time of recruitment (up to 4 children per family)

Able to consent

Disqualifiers

Age 7-10 years old

Intellectual Disability

Does not reside in same household as the mother

Major Axis I disorder (e.g., Autism, Schizophrenia, Bipolar)

Trial design

Treatments tested in this trial

  • Supplemental cash transfer

Treatment groups

450 Participants
are divided into 2 treatment groups

Sponsors and collaborators

New York State Psychiatric Institute

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator